CAS 5451-40-1
:2,6-Dichloropurine
- 1H-Purine, 2,6-dichloro-
- 2,6-Dichloro-1H-purine
- 2,6-Dichloro-9H-purin
- 2,6-dichloro-5H-purine
- 2,6-dichloro-7H-purine
- 2,6-dichloro-9H-purine
- 9H-Purine, 2,6-dichloro-
- NSC 18395
- Purine, 2,6-dichloro-
- 2,6-Dichloropurine
2,6-Dichloropurine
CAS :Formule :C5H2Cl2N4Degré de pureté :>97.0%(T)(HPLC)Couleur et forme :White to Light yellow to Dark green powder to crystalMasse moléculaire :189.002,6-Dichloropurine, 97%
CAS :This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Sci
Formule :C5H2Cl2N4Degré de pureté :97%Couleur et forme :White to pale yellow or pale pink, PowderMasse moléculaire :189.012,6-Dichloropurine
CAS :Formule :C5H2Cl2N4Degré de pureté :97%Couleur et forme :SolidMasse moléculaire :189.00222,6-Dichloro-9H-purine
CAS :2,6-Dichloro-9H-purineFormule :C5H2Cl2N4Degré de pureté :98%Couleur et forme : white to off white powderMasse moléculaire :189.00g/mol2,6-Dichloropurine
CAS :2,6-Dichloropurine is a nitrogenous base that inhibits the activity of certain enzymes in the body. It has been shown to inhibit protease activity and nitro reductases, which are enzymes that metabolize nitrosamines. 2,6-Dichloropurine also inhibits the synthesis of epidermal growth factor (EGF) and adenosine A3 receptors in vivo. This drug has potent antitumor activity against various cancer cells and is used for the treatment of HIV infections. 2,6-Dichloropurine can be synthesized from 6-fluoro-3-indoxyl-beta-D-galactopyranoside with an intramolecular hydrogen atom.
Formule :C5H2Cl2N4Degré de pureté :Min. 98 Area-%Couleur et forme :PowderMasse moléculaire :189 g/mol2,6-Dichloropurine
CAS :Formule :C5H2Cl2N4Degré de pureté :97%Couleur et forme :SolidMasse moléculaire :1892,6-Dichloropurine
CAS :Produit contrôléApplications 2,6-Dichloropurine is used in the synthesis of 2,6-diamino-substituted purine derivatives as potential cardiomyogenesis inducing agents.
References Kelley, J.L., et al.: J. Med. Chem., 31, 2001 (1988), Garcia-Echeverria, C., et al.: Med. Res. Rev., 20, 28 (2000);Formule :C5H2Cl2N4Couleur et forme :WhiteMasse moléculaire :189.00









